Work of a multidisciplinary team in the control of the prescription of ertapenem;Actuación de un equipo multidisplinario en el control de la prescripción de ertapenem

Farmacia Hospitalaria

Volumn 33, Issue 1, 2009, Pages 48-52

  Gil Navarro, M V ^a   Munoz Corte R ^a   Herrero Romero, M ^a   Santos Rubio, M D ^a   Cordero Matia E ^a   Bautista Paloma, J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antibiotics; Antibiotics policies; Antimicrobial management team; Ertapenem; Resistance to antibiotics

Indexed keywords

ERTAPENEM;

ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; INFECTION; LENGTH OF STAY; PRESCRIPTION; TREATMENT DURATION; TREATMENT FAILURE;

EID: 66749182725     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(09)70735-4     Document Type: Editorial

References (22)

1. A.J. Alanis Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36 2005 697 705 (Pubitemid 41436239)
2. Infectious Diseases Society of America. Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. Alexandria, VA: Infectious Diseases Society of America; 2004. [Acceso 15-01-2008] Disponible en: http://www.idsociety.org/badbugsnodrugs.html
3. M.S. Smolinski, M.A. Hamburg, and J. Lederberg Microbial threats to health: emergence, detection, and response 2003 Institute of Medicine Washington, DC
4. B. Spellberg, J.H. Powers, E.P. Brass, L.G. Miller, and J.E. Edwards Trends in antimicrobial drug development: implications for the future Clin Infect Dis 38 2004 1279 1286 (Pubitemid 38608571)
5. G.H. Talbot, J. Bradley, J.E. Edwards Jr, D. Gilbert, M. Scheld, and J.G. Bartlett Bad bugs need drugs: an update on the development pipeline from the Antimicrobial availability. Task Force of the Infectious Diseases Society of America Clin Infect Dis 42 2006 657 668 (Pubitemid 43271379)
6. I.C. Gyssens, and B.J. Kullberg Improving the quality of antimicrobial drug use can result in cost containment Pharm World Sci 17 1995 163 167
7. S.D. Holmberg, S.L. Soloman, and P.A. Blake Health and economic impacts of antimicrobial resistance Rev Infect Dis 90 1987 65 78
8. House of Lords Select Committee on Science and Technology. Resistance to antibiotics. Session 2000-01. 3rd Report. London: The Stationery Office Ltd; 2001.
9. J. Avorn, and D.H. Solomon Cultural and economic factors that (mis) shape antibiotic use: the nonpharmacologic basis of therapeutics Ann Intern Med 133 2000 128 135 (Pubitemid 30490413)
10. Interagency Task Force on Antimicrobial Resistance. Action plan to combat antimicrobial resistance; part 1: domestic. 2001. [Acceso 12-02-2008] Disponible en: http://www.cdc.gov/drugresistance/actionplan/aractionplan.pdf
11. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. [Acceso 20-01-2008] Disponible en: http://www.cdc.gov/ncidod/dhqp/index.html
12. D. Timothy, R. Owens, J. McGowan, D. Gerding, R. Weinstein, and J. Burke Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 2007 159 177 (Pubitemid 46084814)
13. A. García, J. Varela, P. Alonso, I. López, M. Seoane, and M. Pérez Eficacia de la evaluación crítica diaria de las prescripciones de antibióticos restringidos Farm Hosp 22 1998 306 312
14. C. Ramsay, E. Brown, G. Hartman, and P. Davey Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing J Antimicrob Chemother 52 2003 764 771 (Pubitemid 37407802)
15. N.A. Nickman, H.F. Blissenbach, and J.D. Herrick Medical committee enforcement of policy limiting postsurgical antibiotic use Am J Hosp Pharm 41 1984 2053 2056 (Pubitemid 14046176)
16. E. Bouza, J. Cosín Grupo Cooperativo para el Estudio de la Infección Estudio de Prevalencia hospitalaria y consumo de antibióticos Med Clin (Barc) 87 1986 353 358 (Pubitemid 17196934)
17. J. Rodríguez-Baño, and M.D. Navarro Impact of ESBL on empirical therapy and antibiotic policies Enferm Infecc Microbiol Clin 25 Supl 2 2007 54 59
18. A. Apisarnthanarak, S. Danchaivijitr, T.C. Bailey, and V.J. Fraser Inappropriate antibiotic use in a tertiary care center in Thailand: an incidence study and review of experience in Thailand Infect Control Hosp Epidemiol 27 2006 416 420 (Pubitemid 43736110)
19. A. Apisarnthanarak, S. Danchaivijitr, T. Khawcharoenporn, J. Limsrivilai, B. Warachan, and T.C. Bailey Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand Clin Infect Dis 42 2006 768 775 (Pubitemid 43363930)
20. F.W. Arnold, L.C. McDonald, R.S. Smith, D. Newman, and J.A. Ramirez Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians Infect Control Hosp Epidemiol 27 2006 378 382 (Pubitemid 43736103)
21. J. Barenfanger, M.A. Short, and A.A. Groesch Improved antimicrobial interventions have benefits J Clin Microbiol 39 2001 2823 2828 (Pubitemid 32743996)
22. J. Rodriguez-Baño, M.D. Navarro, L. Romero, M.A. Muniain, E.J. Perea, and R. Pérez-Cano Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control Clin Infect Dis 42 2006 37 45 (Pubitemid 41832077)